Then within minutes, the Joint Committee on Vaccination and Immunisation (JCVI) advised the UK Government to roll the jab out to all children deemed to be in a clinical risk group, or who are a household contact of someone who is immunosuppressed.
Professor Wei Shen Lim, Chair of the JCVI said:
“The majority of children aged 5 to 11 are at very low risk of serious illness due to COVID-19. However, some 5 to 11 year olds have underlying health conditions that put them at higher risk, and we advise these children to be vaccinated in the first instance.”
With the alleged Omicron variant about to become the dominant strain in the UK it makes very little sense to give the Pfizer injection to children due to the fact that it only targets the S protein of the virus, which is heavily mutated in Omicron.
But that is not the only reason why children as young as 5 should not be given the Covid-19 injection.
For a parent to be competent enough to make the decision to consent to their child having the Pfizer Covid-19 vaccine, they should be made aware of all the facts before they reach their decision. So we’ve compiled 13 factual reasons why 5 to 11-year-old children should not be given the Covid-19 vaccine…
Reason No. 1
86% of 12-15-year old Children suffered an Adverse Reaction to the Pfizer Covid-19 Vaccine in the Clinical Trial
The information is publicly available and contained within a US Food & Drug Administration (FDA) fact sheet which can be viewed here (see page 25, table 5 on-wards).
That fact sheet contains two tables that detail the alarming rate of side effects and damage experienced by 12 – 15- year-old children who were given at least one dose of the Pfizer mRNA injection.
The tables shows that 1,127 children were given one dose of the mRNA jab, but only 1,097 children received the second dose. This fact in itself raises questions as to why 30 children did not receive a second dose of the Pfizer jab.
Of the 1,127 children who received a first dose of the jab 86% experienced an adverse reaction. Of the 1,097 children who received a second dose of the jab 78.9% experienced an adverse reaction.
Reason No. 2
1 in 9 Children suffered a Severe Adverse Reaction leaving them unable to perform daily activities in the Pfizer Clinical Trial
For children 12 to 15 years of age, the Pfizer Covid-19 vaccine clinical trial found the overall incidence of severe adverse events which left them unable to perform daily activities, during the two-month observation period to be 10.7%, or 1 in 9, in the vaccinated group and 1.9% in the unvaccinated group.
Consequently, children who received the vaccine had nearly six times the risk of a severe adverse event occurring in the two-month observation period compared to children who did not receive the vaccine. In addition, the incidence of Covid-19 in the unvaccinated group was 1.6%, therefore, there were almost seven times more severe adverse events observed in the vaccinated group than there were Covid-19 cases in the unvaccinated group.
This information is all freely available to see in official Food and Drug Administration (FDA) documents and official Centre for Disease Control (CDC) documents.
1 in 9 Children suffered a Severe Adverse Reaction leaving them unable to perform daily activities in the Pfizer Clinical Trial
For children 12 to 15 years of age, the Pfizer Covid-19 vaccine clinical trial found the overall incidence of severe adverse events which left them unable to perform daily activities, during the two-month observation period to be 10.7%, or 1 in 9, in the vaccinated group and 1.9% in the unvaccinated group.
Consequently, children who received the vaccine had nearly six times the risk of a severe adverse event occurring in the two-month observation period compared to children who did not receive the vaccine. In addition, the incidence of Covid-19 in the unvaccinated group was 1.6%, therefore, there were almost seven times more severe adverse events observed in the vaccinated group than there were Covid-19 cases in the unvaccinated group.
This information is all freely available to see in official Food and Drug Administration (FDA) documents and official Centre for Disease Control (CDC) documents.
Reason No. 3
Just 17 deaths associated with Covid-19 have occurred in Teenagers & Children since March 2020
Official NHS data which can be viewed here (see Table 3 – COVID-19 deaths by age group and pre-existing condition of the downloadable excel document) shows that since March 2020 just 17 people under the age of 19 have died with Covid-19 who had no known pre-existing conditions in England’s hospitals, up to the 8th December 2021. The data also shows that just 60 people under the age of 19 have died with Covid-19 in the same time frame who did have other serious underlying conditions.
There are approximately 15.6 million people aged 19 and under in the United Kingdom which means just 1 in every 260,000 children and teenagers have allegedly died with Covid-19 in 21 months who had other serious pre-existing conditions. Whilst just 1 in every 917,647 children have allegedly died with Covid-19 in 21 months, who had no know pre-existing conditions.
A scientific study titled ‘Deaths in Children and Young People in England following SARS-CoV-2 infection during the first pandemic year: a national study using linked mandatory child death reporting data’ (which can be found here), conducted by Clare Smith of NHS England and Improvement and several Universities also concluded that children are at negligible risk of death, hospitalisation, or serious illness due to the alleged Covid-19 virus.
The study collated data from the National Child Mortality Database; a mandatory system that records all deaths in Children under 18 years of age in England. What the researchers found is that just 25 children under the age of 18 died of Covid-19 between March 2020 and February 2021, with 15 of the 25 having a pre-existing life-limiting condition, and 19 of the 25 having a chronic condition.
The study also found that 16 of the 25 children who sadly died had two or more comorbidities with 8 children suffering pre-existing neurological and respiratory problems, 3 children suffering pre-existing neurological and cardiology problems, and 3 children suffering respiratory and cardiology problems.
Just 17 deaths associated with Covid-19 have occurred in Teenagers & Children since March 2020
Official NHS data which can be viewed here (see Table 3 – COVID-19 deaths by age group and pre-existing condition of the downloadable excel document) shows that since March 2020 just 17 people under the age of 19 have died with Covid-19 who had no known pre-existing conditions in England’s hospitals, up to the 8th December 2021. The data also shows that just 60 people under the age of 19 have died with Covid-19 in the same time frame who did have other serious underlying conditions.
There are approximately 15.6 million people aged 19 and under in the United Kingdom which means just 1 in every 260,000 children and teenagers have allegedly died with Covid-19 in 21 months who had other serious pre-existing conditions. Whilst just 1 in every 917,647 children have allegedly died with Covid-19 in 21 months, who had no know pre-existing conditions.
A scientific study titled ‘Deaths in Children and Young People in England following SARS-CoV-2 infection during the first pandemic year: a national study using linked mandatory child death reporting data’ (which can be found here), conducted by Clare Smith of NHS England and Improvement and several Universities also concluded that children are at negligible risk of death, hospitalisation, or serious illness due to the alleged Covid-19 virus.
The study collated data from the National Child Mortality Database; a mandatory system that records all deaths in Children under 18 years of age in England. What the researchers found is that just 25 children under the age of 18 died of Covid-19 between March 2020 and February 2021, with 15 of the 25 having a pre-existing life-limiting condition, and 19 of the 25 having a chronic condition.
The study also found that 16 of the 25 children who sadly died had two or more comorbidities with 8 children suffering pre-existing neurological and respiratory problems, 3 children suffering pre-existing neurological and cardiology problems, and 3 children suffering respiratory and cardiology problems.
Reason No. 4
The risk of Children developing serious illness due to Covid-19 is extremely low
A study (found here) led by Professor Russell Viner of UCL Great Ormond Street Institute of Child Health, published on the medRxiv server, found that 251 young people aged under 18 in England were admitted to intensive care with Covid-19 during the first year of the pandemic (until the end of February 2021).
The results of the study found that there were 5,830 admissions associated with Covid-19 among children up to 17 years of age during the pandemic year, this represents just 1.3% of secondary care admissions among children.
The lead author of the study said: “These new studies show that the risks of severe illness or death from SARS-CoV-2 are extremely low in children and young people”.
The risk of Children developing serious illness due to Covid-19 is extremely low
A study (found here) led by Professor Russell Viner of UCL Great Ormond Street Institute of Child Health, published on the medRxiv server, found that 251 young people aged under 18 in England were admitted to intensive care with Covid-19 during the first year of the pandemic (until the end of February 2021).
The results of the study found that there were 5,830 admissions associated with Covid-19 among children up to 17 years of age during the pandemic year, this represents just 1.3% of secondary care admissions among children.
The lead author of the study said: “These new studies show that the risks of severe illness or death from SARS-CoV-2 are extremely low in children and young people”.
Reason No. 5
The Pfizer Covid-19 Vaccine is experimental and still in Clinical Trials
The Pfizer mRNA Covid-19 injection is in fact only temporarily authorised (see official MHRA document here) for emergency use only. In October the government made changes to the Human Medicines Regulations 2012 to allow the MHRA to grant temporary authorisation of a Covid-19 vaccine without needing to wait for the EMA.
A temporary use authorisation is valid for one year only and requires the pharmaceutical companies to complete specific obligations, such as ongoing or new studies. Once comprehensive data on the product have been obtained, standard marketing authorisation can be granted. This means that the manufacturer of the vaccine cannot be held liable for any injury or death that occurs due to their vaccine, unless it was due to a quality control issue.
The reason the Pfizer mRNA Covid-19 injection has only been granted temporary authorisation is because it is still in clinical trials that are not set to conclude until May 2nd 2023. You can see the official Clinical Trial Study Tracker for the Pfizer jab on the US National Library of Medicine site here.
This is the first time mRNA injections have ever been authorised for use in humans (see here), and the long term side effects are not known, meaning the millions of people around the world who have had the Pfizer Covid-19 injection are essentially taking part in an experiment.
Reason No. 6
Three Scientific Studies conducted by the UK Government, Oxford University, & CDC, which were published in August have found the Covid-19 Vaccines do not work...
The Pfizer Covid-19 Vaccine is experimental and still in Clinical Trials
The Pfizer mRNA Covid-19 injection is in fact only temporarily authorised (see official MHRA document here) for emergency use only. In October the government made changes to the Human Medicines Regulations 2012 to allow the MHRA to grant temporary authorisation of a Covid-19 vaccine without needing to wait for the EMA.
A temporary use authorisation is valid for one year only and requires the pharmaceutical companies to complete specific obligations, such as ongoing or new studies. Once comprehensive data on the product have been obtained, standard marketing authorisation can be granted. This means that the manufacturer of the vaccine cannot be held liable for any injury or death that occurs due to their vaccine, unless it was due to a quality control issue.
The reason the Pfizer mRNA Covid-19 injection has only been granted temporary authorisation is because it is still in clinical trials that are not set to conclude until May 2nd 2023. You can see the official Clinical Trial Study Tracker for the Pfizer jab on the US National Library of Medicine site here.
This is the first time mRNA injections have ever been authorised for use in humans (see here), and the long term side effects are not known, meaning the millions of people around the world who have had the Pfizer Covid-19 injection are essentially taking part in an experiment.
Reason No. 6
Three Scientific Studies conducted by the UK Government, Oxford University, & CDC, which were published in August have found the Covid-19 Vaccines do not work...
URISKO TWEET.
